SILVERARC CAPITAL MANAGEMENT, LLC
Filing Date
Global Rank
#1,953
/ 8,605
▲ 300
· as of Mar 2026
Top Industry
Biotechnology
92.4%
3Y Alpha vs SPY
-6.3%
Period ended 3 months ago
Filed May 14, 2026 · 56d
22 quarters · since Dec 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+47.8%
SPY
+76.5%
Annualised alpha
-7.0%
Max drawdown
−56.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
65 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
6.8%
−1.4 pts
Top 5
28.9%
−2.7 pts
Top 10
49.1%
−2.7 pts
HHI
341
Diversified−16
Portfolio Trend
22 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 98.5% | $834,765,918 |
| Financial Services | 1.5% | $12,283,297 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | +972,974 | 2,002,040 | $32,933,558 | |
| IMNM | Immunome Inc. | +724,068 | 1,850,278 | $40,465,579 | |
| ERAS | Erasca, Inc. | +534,228 | 1,851,812 | $29,962,318 | |
| KALV | KalVista Pharmaceuticals, Inc. | +449,289 | 2,876,407 | $57,902,072 | |
| CERS | Cerus Corp | +362,164 | 3,176,547 | $5,781,315 | |
| SNDX | Syndax Pharmaceuticals Inc | +246,088 | 888,987 | $20,766,736 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +170,050 | 306,000 | $26,612,820 | |
| IBIO | iBio, Inc. | +120,000 | 226,000 | $429,400 | |
| ASND | Ascendis Pharma A/S | +75,430 | 124,658 | $28,513,024 | |
| COGT | Cogent Biosciences, Inc. | +68,935 | 1,314,189 | $50,583,134 | |
| NUVL | Nuvalent, Inc. | +43,484 | 354,914 | $36,360,939 | |
| FULC | Fulcrum Therapeutics, Inc. | +25,299 | 419,949 | $3,221,008 | |
| ABEO | Abeona Therapeutics Inc. | +21,204 | 648,942 | $2,907,260 | |
| CNTA | Centessa Pharmaceuticals plc | +8,142 | 466,345 | $18,523,223 | |
| GH | Guardant Health, Inc. | +6,600 | 98,514 | $9,099,738 | |
| EWTX | Edgewise Therapeutics, Inc. | +563 | 42,615 | $1,342,372 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GUTS | Fractyl Health, Inc. | −8,138,416 | 1,701,625 | $779,344 | |
| TELA | TELA Bio, Inc. | −388,200 | 2,259,312 | $1,400,773 | |
| AARD | Aardvark Therapeutics, Inc. | −270,255 | 33,684 | $126,988 | |
| ADGM | Adagio Medical Holdings, Inc. | −263,412 | 251,972 | $289,767 | |
| ELUT | Elutia Inc. | −253,294 | 2,498,020 | $2,622,921 | |
| URGN | UroGen Pharma Ltd. | −235,776 | 1,503,045 | $27,024,749 | |
| CGON | CG Oncology, Inc. | −194,809 | 166,349 | $11,258,500 | |
| CMPX | Compass Therapeutics, Inc. | −192,294 | 859,049 | $4,544,369 | |
| VCYT | Veracyte, Inc. | −177,858 | 179,700 | $5,788,137 | |
| CGEN | Compugen Ltd | −163,960 | 3,315,845 | $7,062,749 | |
| ABVX | Abivax S.A. | −119,663 | 302,530 | $33,686,715 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −95,390 | 654,746 | $54,946,284 | |
| CCCC | C4 Therapeutics, Inc. | −82,439 | 1,911,785 | $5,027,994 | |
| INSM | INSMED Inc | −35,406 | 35,850 | $5,862,192 | |
| KOD | Kodiak Sciences Inc. | −31,192 | 991,930 | $37,812,371 | |
| TRVI | Trevi Therapeutics, Inc. | −30,113 | 511,127 | $6,097,745 | |
| BIIB | Biogen Inc. | −24,445 | 50,967 | $9,343,780 | |
| CELC | Celcuity Inc. | −17,229 | 357,903 | $40,851,048 | |
| ORIC | Oric Pharmaceuticals, Inc. | −16,594 | 1,100,010 | $13,937,126 | |
| BNTC | Benitec Biopharma Inc. | −13,992 | 717,725 | $7,643,771 | |
| SRZN | Surrozen, Inc./DE | −13,068 | 144,255 | $4,202,148 | |
| CLDX | Celldex Therapeutics, Inc. | −12,696 | 178,378 | $5,658,150 | |
| PRAX | Praxis Precision Medicines, Inc. | −10,913 | 71,552 | $23,053,338 | |
| CTNM | Contineum Therapeutics, Inc. | −5,811 | 301,729 | $3,940,580 | |
| PCVX | Vaxcyte, Inc. | −3,806 | 144,981 | $8,424,845 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
20 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | 1,135,935 | $22,207,529 | |
| SRRK | Scholar Rock Holding Corp | 339,613 | $16,695,375 | |
| ALKS | Alkermes plc. | 460,314 | $16,276,703 | |
| IRON | Disc Medicine, Inc. | 196,028 | $12,534,030 | |
| HLXC | Helix Acquisition Corp. III | 1,208,986 | $12,283,297 | |
| XENE | Xenon Pharmaceuticals Inc. | 197,759 | $11,499,685 | |
| IMVT | Immunovant, Inc. | 414,236 | $10,289,622 | |
| SVRA | Savara Inc | 1,430,982 | $7,813,161 | |
| ORKA | Oruka Therapeutics, Inc. | 150,908 | $7,402,037 | |
| CYTK | Cytokinetics Inc | 71,203 | $4,692,989 | |
| CLYM | Climb Bio, Inc. | 684,908 | $4,691,619 | |
| ZURA | Zura Bio Ltd | 560,651 | $3,335,873 | |
| CAMP | Camp4 Therapeutics Corp | 653,594 | $2,882,349 | |
| ANNX | Annexon, Inc. | 496,461 | $2,750,393 | |
| CBIO | Crescent Biopharma, Inc. | 130,500 | $2,397,285 | |
| MNPR | Monopar Therapeutics | 43,488 | $2,382,707 | |
| OVID | Ovid Therapeutics Inc. | 1,000,000 | $2,220,000 | |
| CMPS | COMPASS Pathways plc | 300,000 | $1,659,000 | |
| REPL | Replimune Group, Inc. | 171,936 | $1,315,310 | |
| GENB | Generate Biomedicines, Inc. | 100,000 | $1,250,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
18 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.DE | 348,569 | $10,847,467 | |
| PFE | Pfizer Inc | 419,134 | $10,436,436 | |
| AVTX | Avalo Therapeutics, Inc. | 524,436 | $9,523,757 | |
| GOSS | Gossamer Bio, Inc. | 2,135,722 | $6,620,738 | |
| LXEO | Lexeo Therapeutics, Inc. | 617,608 | $6,132,847 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | 506,242 | $6,115,403 | |
| SLNO | Soleno Therapeutics Inc | 117,485 | $5,439,555 | |
| OLMA | Olema Pharmaceuticals, Inc. | 206,280 | $5,157,000 | |
| MLYS | Mineralys Therapeutics, Inc. | 94,983 | $3,446,933 | |
| RLAY | Relay Therapeutics, Inc. | 398,167 | $3,368,492 | |
| QURE | uniQure N.V. | 126,047 | $3,016,304 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 36,124 | $2,957,833 | |
| KYMR | Kymera Therapeutics, Inc. | 34,589 | $2,691,370 | |
| CTMX | CytomX Therapeutics, Inc. | 385,974 | $1,644,249 | |
| XFOR | X4 Pharmaceuticals, Inc | 357,387 | $1,429,548 | |
| FDMT | 4D Molecular Therapeutics, Inc. | 100,000 | $750,000 | |
| RAPP | Rapport Therapeutics, Inc. | 9,659 | $293,054 | |
| PALI | Palisade Bio, Inc. | 102,108 | $239,953 | |
| No positions match the current search. | ||||
65 positions ·
$847,049,215 total
· as of Mar 31, 2026
Showing 1–50
of 65 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Added | 2,876,407 | $57,902,072 | 6.84% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 654,746 | $54,946,284 | 6.49% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 1,314,189 | $50,583,134 | 5.97% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 357,903 | $40,851,048 | 4.82% | |
| IMNM |
Immunome Inc.
Healthcare
|
Added | 1,850,278 | $40,465,579 | 4.78% | |
| KOD |
Kodiak Sciences Inc.
Healthcare
|
Reduced | 991,930 | $37,812,371 | 4.46% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 354,914 | $36,360,939 | 4.29% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 302,530 | $33,686,715 | 3.98% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 2,002,040 | $32,933,558 | 3.89% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 1,851,812 | $29,962,318 | 3.54% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 124,658 | $28,513,024 | 3.37% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Reduced | 1,503,045 | $27,024,749 | 3.19% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 306,000 | $26,612,820 | 3.14% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 71,552 | $23,053,338 | 2.72% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
NEW | 1,135,935 | $22,207,529 | 2.62% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 888,987 | $20,766,736 | 2.45% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 466,345 | $18,523,223 | 2.19% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
NEW | 339,613 | $16,695,375 | 1.97% | |
| ALKS |
Alkermes plc.
Healthcare
|
NEW | 460,314 | $16,276,703 | 1.92% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,100,010 | $13,937,126 | 1.65% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
NEW | 196,028 | $12,534,030 | 1.48% | |
| HLXC |
Helix Acquisition Corp. III
Financial Services
|
NEW | 1,208,986 | $12,283,297 | 1.45% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 197,759 | $11,499,685 | 1.36% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 166,349 | $11,258,500 | 1.33% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
NEW | 414,236 | $10,289,622 | 1.21% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 186,618 | $9,413,011 | 1.11% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 50,967 | $9,343,780 | 1.10% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Added | 98,514 | $9,099,738 | 1.07% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 144,981 | $8,424,845 | 0.99% | |
| SVRA |
Savara Inc
Healthcare
|
NEW | 1,430,982 | $7,813,161 | 0.92% | |
| BNTC |
Benitec Biopharma Inc.
Healthcare
|
Reduced | 717,725 | $7,643,771 | 0.90% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 150,908 | $7,402,037 | 0.87% | |
| CGEN |
Compugen Ltd
Healthcare
|
Reduced | 3,315,845 | $7,062,749 | 0.83% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Reduced | 511,127 | $6,097,745 | 0.72% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 35,850 | $5,862,192 | 0.69% | |
| VCYT |
Veracyte, Inc.
Healthcare
|
Reduced | 179,700 | $5,788,137 | 0.68% | |
| CERS |
Cerus Corp
Healthcare
|
Added | 3,176,547 | $5,781,315 | 0.68% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 178,378 | $5,658,150 | 0.67% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
Reduced | 1,911,785 | $5,027,994 | 0.59% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 71,203 | $4,692,989 | 0.55% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
NEW | 684,908 | $4,691,619 | 0.55% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 859,049 | $4,544,369 | 0.54% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Reduced | 144,255 | $4,202,148 | 0.50% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Reduced | 301,729 | $3,940,580 | 0.47% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
NEW | 560,651 | $3,335,873 | 0.39% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Added | 419,949 | $3,221,008 | 0.38% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
Added | 648,942 | $2,907,260 | 0.34% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
NEW | 653,594 | $2,882,349 | 0.34% | |
| ANNX |
Annexon, Inc.
Healthcare
|
NEW | 496,461 | $2,750,393 | 0.32% | |
| ELUT |
Elutia Inc.
Healthcare
|
Reduced | 2,498,020 | $2,622,921 | 0.31% |